Innovator IBD Breakout Opportunities ETF (BOUT)

Assets	$12.88M
Expense Ratio	0.85%
PE Ratio	27.82
Shares Out	350,000
Dividend (ttm)	$0.23
Dividend Yield	0.63%
Ex-Dividend Date	Dec 31, 2024
Payout Ratio	17.61%
1-Year Return	+1.66%

Volume	1,304
Open	37.01
Previous Close	37.09
Day's Range	36.84 - 37.01
52-Week Low	32.53
52-Week High	42.41
Beta	0.99
Holdings	40
Inception Date	Sep 13, 2018

About BOUT

Fund Home Page

The Innovator IBD Breakout Opportunities ETF (BOUT) is an exchange-traded fund that is based on the IBD Breakout Stocks Total Return index. The fund tracks an index of US-listed stocks that are likely to breakout, as determined by technical analysis. Holdings are weighted by a mix of fundamental and technical factors BOUT was launched on Sep 13, 2018 and is issued by Innovator.

• Asset Class: Equity
• Category: Mid-Cap Growth
• Region: North America
• Stock Exchange: NYSEARCA
• Ticker Symbol: BOUT
• ETF Provider: Innovator
• Index Tracked: IBD Breakout Stocks Total Return

Top 10 Holdings

47.78% of assets

Name	Symbol	Weight
Ascendis Pharma A/S	ASND	5.45%
Old Republic International Corporation	ORI	5.07%
Linde plc	LIN	5.05%
The Southern Company	SO	4.97%
Essential Utilities, Inc.	WTRG	4.90%
EHang Holdings Limited	EH	4.79%
Nexstar Media Group, Inc.	NXST	4.49%
Kratos Defense & Security Solutions, Inc.	KTOS	4.36%
Amgen Inc.	AMGN	4.35%
Enterprise Products Partners L.P.	EPD	4.34%

Dividends

Ex-Dividend	Amount	Pay Date
Dec 31, 2024	$0.22753	Jan 2, 2025
Jul 31, 2024	$0.0059	Aug 1, 2024
Dec 28, 2023	$0.43704	Jan 2, 2024
Dec 29, 2022	$0.39823	Jan 3, 2023
Dec 27, 2018	$0.03888	Jan 2, 2019